Amgen's MariTide challenges Lilly and Novo but falls short ... Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau As Nicholas ...

StudyFinds' Dr. Faith Coleman explains what happens when patients stop taking popular weight loss medications.

In today’s digital age, data is a company’s most valuable asset. A single instance of data loss can lead to severe consequences, from hefty fines for violating data privacy laws like GDPR and CCPA to ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Power walking, or moving your arms during your walk, can also help burn more calories, reports Gloucestershire Live. The ...

Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

Conditions that cause unexplained weight loss include overactive thyroid, inflammatory bowel disease, and depression. Because unintentional weight loss can happen due to various health conditions ...

Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

The Very Group has posted a 4.9% decrease in first quarter group revenue to £450.2 million as the business continued to face a challenging market in the period. Accounting for 87% of sales, the ...

58% of respondents said they would be inclined to try a medically supported weight loss program if it offered personalized meal plans and a support group. "Weight loss is a journey that requires a ...